沉默KRIT1部分扭转了干扰流动对内皮细胞转录组的影响
Amelia Meecham1, Sara McCurdy1, Eduardo Frias-Anaya1
1Department of Medicine, University of California, San Diego, La Jolla, CA 92093.
bioRxiv : the preprint server for biology
|March 31, 2025
概括
静止内皮细胞中的KRIT1可以在血液流动受损的情况下恢复保护性KLF2/KLF4基因表达. 这一发现表明,向CCM复合体可以通过增强内皮细胞的弹性来预防动脉样硬化.
科学领域:
- 内皮细胞生物学 内皮细胞生物学
- 动脉样硬化的分子机制
- 转录学和基因调节学
背景情况:
- 内皮细胞通过对血流剪切应激的反应来调节血管健康,主要由克鲁佩尔样因子2和4 (KLF2和KLF4) 介导.
- 与动脉样硬化相关的血液流动障碍会降低KLF2和KLF4的表达,促进炎症和血栓形成.
- 内皮细胞-细胞分子 (CCM) 综合体,包括KRIT1,通常会抑制KLF2和KLF4;其功能丧失可能会防止动脉样硬化.
研究的目的:
- 调查是否沉默KRIT1,CCM复合体的关键组成部分,可以正常化破坏血液流动对人类内皮细胞转录组的有害影响.
- 为了确定KRIT1沉默是否可以恢复受干扰流动影响的内皮细胞中的动脉保护基因表达模式.
主要方法:
- 人的静脉内皮细胞 (HUVECs) 使用小干扰RNA (siRNAs) 进行了KRIT1基因沉默.
- 细胞在24小时内受到不同的流量条件:层状 (脉动式剪切应力),扰动 (振荡式剪切应力) 和静态 (无流量).
- 进行了大量RNA测序 (RNA-seq) 来分析转录组变化.
主要成果:
- 在HUVEC中抑制KRIT1成功地在振荡式剪切应力条件下恢复了KLF2和KLF4的表达.
- 在受干扰流量的情况下,KRIT1沉默细胞的转录形状与正常层流下的细胞非常相似.
- 这些结果表明,抑制CCM复合体会在内皮细胞中重新激活血管保护性基因程序.
结论:
- 抑制CCM复合体,特别是KRIT1,通过增强内皮细胞对血流干扰的抵抗力来增强血管保护.
- 准CCM基因可以激活保护性通路,为预防动脉样硬化提供一种新的治疗策略.
- 这种方法促进内皮对炎症的抵抗,缺氧,并支持在动脉质条件下血管生成.
更多相关视频
10:44In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
1.4K
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
9.5K
相关概念视频
siRNA - Small Interfering RNAs
16.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.4K
Experimental RNAi
6.0K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K
Eukaryotic Transcription Inhibitors
9.7K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
9.7K
Small interfering RNAs (siRNA)
3.4K
3.4K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
